カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の非経口栄養剤市場2023-2030：ステージ種類別（成人、小児）、栄養素種類別、疾患別、販売チャネル別、地域別

【英語タイトル】Parenteral Nutrition Market Size, Share & Trends Analysis Report By Stage Type (Adults, Pediatrics), By Nutrient Type, By Indication, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23AUG061）・商品コード：GRV23AUG061
・発行会社（調査会社）：Grand View Research
・発行日：2023年7月25日
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

非経口栄養剤市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の非経口栄養剤市場規模は2030年までに107億米ドルに達し、予測期間中のCAGRは6.0%を記録する見込みです。がん、糖尿病、その他の神経疾患などの慢性疾患の増加、重症患者における必須栄養不足の急増、および病院関連の栄養失調に関する意識の高まりは、非経口栄養剤の採用を増加させるいくつかの重要な要因です。非経口的薬剤投与は、即効性と低用量投与という利点を提供し、食事の不均衡によるさまざまな副作用を防ぐため、市場の成長を促進します。

しかし、投与中の感染リスクが高いことや、患者の間で経腸栄養への嗜好が高まっていることが、市場の成長を抑制する主な要因となっています。人口の増加に伴い、家庭や国家の医療費と食費は増加の一途をたどっています。したがって、出生率の上昇は栄養水準に影響を与えると予想され、それによって市場のドライバーとして機能します。出生率には、出生1件当たりの水、食料、投薬の必要量など、環境面だけでなく資源面での圧力も含まれるため、絶対的出生率（粗出生率）よりも現実化出生率の方が重要な役割を果たします。現実化された出生率は過去10年間で増加しており、予測期間中も成長を維持すると予想されます。

2020年、全米保健統計センター（NCHS）が報告する出生率は、人口1,000人当たり11.99人です。また、低体重児の割合は8.0%であり、世界的にPN製品に対する需要が高まっています。さらに、60歳以上の高齢者が多く、免疫力が低く、神経疾患、心臓疾患、癌、脊椎損傷などの発症が多いことが、予測期間中、非経口用脂質エマルション市場にとってインパクトのあるレンダリング要因となっています。このような人々は最新の外科治療を利用することが予想され、それによって寿命が延び、脂質乳剤のようなPN製品を含む集中治療と術後治療の必要性が高まると予想されます。

非経口栄養剤市場レポートハイライト

- 市場で事業を展開する主要企業は、主に患者の安全性を高めることに注力しています。各社はまた、バーコード支援投薬などの技術を取り入れることで、非経口栄養剤の配合を補完するPN製品の進歩にも注力しています。

- 改善された脂質およびタンパク質製剤を患者に提供する能力は、企業が競合他社から自社製品を差別化するために活用する重要なパラメータの1つです。

- また、感染率の高さ、劣悪な水質と衛生設備、認識不足は、発展途上国における栄養不良の発生率を増加させる一般的な要因であり、これがPN源に対する大きな需要を生み出し、市場の成長を助長しています。

- 2022年には、副作用の少ない新しいアミノ酸溶液の導入により、単回投与アミノ酸溶液栄養剤タイプが市場を支配しました。

- 2022年には、この年齢層におけるアルツハイマー病、サルコペニア、がん、糖尿病などのさまざまな慢性疾患の有病率の上昇に起因する非経口栄養剤製品の採用増加により、成人セグメントが最大のシェアを維持しました。

- クローン病、嚢胞性線維症、膵炎、その他のがん関連治療、その他の健康疾患の有病率の増加により、2022年にはその他の適応症セグメントが市場を支配しました。

- 2022年には、私立・公立医療機関の多さと慢性疾患患者の増加により、施設販売チャネルが市場を席巻しました。

- 2022年の世界市場は、慢性疾患と栄養不良の罹患率の上昇に加え、同地域における米国FDA認可の増加により、北米が支配的でした。

第1章. 調査手法＆範囲
第2章. エグゼクティブサマリー
第3章. 非経口栄養剤の市場変動・動向・範囲
第4章. 非経口栄養剤市場：栄養タイプ別予測＆動向分析
第5章. 非経口栄養剤市場：ステージタイプ別予測＆動向分析
第6章. 非経口栄養剤市場：疾患別予測＆動向分析
第7章. 非経口栄養剤市場：販売チャネル別予測＆動向分析
第8章. 非経口栄養剤市場：地域別予測＆動向分析
第9章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Process
1.2. Information Procurement
1.2.1. Purchased database
1.2.1.1. GVR’s internal database
1.2.2. Market Formulation & Validation
1.3. Research Methodology
1.4. Research Scope and Assumptions
1.5. Research Methodology
1.5.1. Region Market: CAGR Calculation
1.5.2. Region Based Segment Share Calculation
1.6. List To Data Nutrient Type
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.4. Parenteral Nutrition Market Snapshot
Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. User Perspective Analysis
3.2.1. Consumer Behavior Analysis
3.2.2. Market Influencer Analysis
3.3. Regulatory Framework
3.3.1. Reimbursement Framework
3.3.2. Standard & Compliance
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenge
3.5. Parenteral Nutrition Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Bargaining power of the suppliers
3.5.1.2. Bargaining power of the buyers
3.5.1.3. Threats of substitution
3.5.1.4. Threats from new entrants
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Economic and Social landscape
3.5.2.3. Technological landscape
3.6. Impact of COVID 19 on Parenteral Nutrition Market
Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Parenteral Nutrition Market: Nutrient Type Movement Analysis, 2022 & 2030 (USD Million)
4.2.1. Carbohydrates
4.2.1.1. Carbohydrates Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.2. Parenteral Lipid Emulsion
4.2.2.1. Parenteral Lipid Emulsion Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.3. Single Dose Amino Acid Solution
4.2.3.1. Single Dose Amino Acid Solution Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.4. Trace Elements
4.2.4.1. Trace Elements Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.5. Vitamins & Minerals
4.2.5.1. Vitamins & Minerals Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Parenteral Nutrition Market: Stage Type Movement Analysis, 2022 & 2030 (USD Million)
5.2.1. Adult
5.2.1.1. Adult Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.2.2. Pediatrics
5.2.2.1. Pediatrics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Parenteral Nutrition Market: Indication Movement Analysis, 2022 & 2030 (USD Million)
6.2.1. Alzheimer’s
6.2.1.1. Alzheimer’s Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.2. Nutrition Deficiency
6.2.2.1. Nutrition Deficiency Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.3. Cancer Care
6.2.3.1. Cancer Care Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.4. Diabetes
6.2.4.1. Diabetes Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.5. Chronic Kidney Disease
6.2.5.1. Chronic Kidney Disease Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.6. Orphan Disease
6.2.6.1. Orphan Disease Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.7. Dysphagia
6.2.7.1. Dysphagia Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.8. Pain Management
6.2.8.1. Pain Management Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.9. Malabsorption/GI Disorder/Diarrhea
6.2.9.1. Malabsorption/GI Disorder/Diarrhea Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.10. Others
6.2.10.1. Others Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Parenteral Nutrition Market: Sales Channel Movement Analysis, 2022 & 2030 (USD Million)
7.2.1. Online Sales
7.2.1.1. Online Sales Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.2. Retail Sales
7.2.2.1. Retail Sales Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.3. Institutional Sales
7.2.3.1. Institutional Sales Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis
8.1. Definition & Scope
8.2. Regional Market Share Analysis, 2022 & 2030
8.3. Regional Market Dashboard
8.4. Regional Market Snapshot
8.5. Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
8.5.1. North America
8.5.1.1. North America Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.1.2. U.S.
8.5.1.2.1. Key Country Dynamics
8.5.1.2.2. Competitive Scenario
8.5.1.2.3. Regulatory Framework
8.5.1.2.4. Reimbursement Scenario
8.5.1.2.5. U.S. Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.1.3. Canada
8.5.1.3.1. Key Country Dynamics
8.5.1.3.2. Competitive Scenario
8.5.1.3.3. Regulatory Framework
8.5.1.3.4. Reimbursement Scenario
8.5.1.3.5. Canada Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2. Europe
8.5.2.1. Europe Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2.2. UK
8.5.2.2.1. Key Country Dynamics
8.5.2.2.2. Competitive Scenario
8.5.2.2.3. Regulatory Framework
8.5.2.2.4. Reimbursement Scenario
8.5.2.2.5. UK Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2.3. Germany
8.5.2.3.1. Key Country Dynamics
8.5.2.3.2. Competitive Scenario
8.5.2.3.3. Regulatory Framework
8.5.2.3.4. Reimbursement Scenario
8.5.2.3.5. Germany Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2.4. France
8.5.2.4.1. Key Country Dynamics
8.5.2.4.2. Competitive Scenario
8.5.2.4.3. Regulatory Framework
8.5.2.4.4. Reimbursement Scenario
8.5.2.4.5. France Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2.5. Italy
8.5.2.5.1. Key Country Dynamics
8.5.2.5.2. Competitive Scenario
8.5.2.5.3. Regulatory Framework
8.5.2.5.4. Reimbursement Scenario
8.5.2.5.5. Italy Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2.6. Spain
8.5.2.6.1. Key Country Dynamics
8.5.2.6.2. Competitive Scenario
8.5.2.6.3. Regulatory Framework
8.5.2.6.4. Reimbursement Scenario
8.5.2.6.5. Spain Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2.7. Denmark
8.5.2.7.1. Key Country Dynamics
8.5.2.7.2. Competitive Scenario
8.5.2.7.3. Regulatory Framework
8.5.2.7.4. Reimbursement Scenario
8.5.2.7.5. Denmark Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2.8. Sweden
8.5.2.8.1. Key Country Dynamics
8.5.2.8.2. Competitive Scenario
8.5.2.8.3. Regulatory Framework
8.5.2.8.4. Reimbursement Scenario
8.5.2.8.5. Sweden Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.2.9. Norway
8.5.2.9.1. Key Country Dynamics
8.5.2.9.2. Competitive Scenario
8.5.2.9.3. Regulatory Framework
8.5.2.9.4. Reimbursement Scenario
8.5.2.9.5. Norway Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.3. Asia Pacific
8.5.3.1. Asia Pacific Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.3.2. Japan
8.5.3.2.1. Key Country Dynamics
8.5.3.2.2. Competitive Scenario
8.5.3.2.3. Regulatory Framework
8.5.3.2.4. Reimbursement Scenario
8.5.3.2.5. Japan Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.3.3. India
8.5.3.3.1. Key Country Dynamics
8.5.3.3.2. Competitive Scenario
8.5.3.3.3. Regulatory Framework
8.5.3.3.4. Reimbursement Scenario
8.5.3.3.5. India Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.3.4. China
8.5.3.4.1. Key Country Dynamics
8.5.3.4.2. Competitive Scenario
8.5.3.4.3. Regulatory Framework
8.5.3.4.4. Reimbursement Scenario
8.5.3.4.5. China Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.3.5. Australia
8.5.3.5.1. Key Country Dynamics
8.5.3.5.2. 8. 6. 3.5Competitive Scenario
8.5.3.5.3. Regulatory Framework
8.5.3.5.4. Reimbursement Scenario
8.5.3.5.5. Australia Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.3.6. Thailand
8.5.3.6.1. Key Country Dynamics
8.5.3.6.2. 8. Competitive Scenario
8.5.3.6.3. Regulatory Framework
8.5.3.6.4. Reimbursement Scenario
8.5.3.6.5. Thailand Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.3.7. South Korea
8.5.3.7.1. Key Country Dynamics
8.5.3.7.2. 8. 6. 3.7Competitive Scenario
8.5.3.7.3. Regulatory Framework
8.5.3.7.4. Reimbursement Scenario
8.5.3.7.5. South Korea Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.6 Latin America
8.5.6.1. Latin America Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.6.2. Brazil
8.5.6.2.1. Key Country Dynamics
8.5.6.2.2. Competitive Scenario
8.5.6.2.3. Regulatory Framework
8.5.6.2.4. Reimbursement Scenario
8.5.6.2.5. Brazil Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.6.3. Mexico
8.5.6.3.1. Key Country Dynamics
8.5.6.3.2. Competitive Scenario
8.5.6.3.3. Regulatory Framework
8.5.6.3.4. Reimbursement Scenario
8.5.6.3.5. 6. 4.3.5 Mexico Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.6.4. Argentina
8.5.6.4.1. Key Country Dynamics
8.5.6.4.2. Competitive Scenario
8.5.6.4.3. Regulatory Framework
8.5.6.4.4. Reimbursement Scenario
8.5.6.4.5. Argentina Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.7. MEA
8.5.7.1. MEA Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.7.2. South Africa
8.5.7.2.1. Key Country Dynamics
8.5.7.2.2. Competitive Scenario
8.5.7.2.3. Regulatory Framework
8.5.7.2.4. Reimbursement Scenario
8.5.7.2.5. South Africa Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.7.3. Saudi Arabia
8.5.7.3.1. Key Country Dynamics
8.5.7.3.2. Competitive Scenario
8.5.7.3.3. Regulatory Framework
8.5.7.3.4. Reimbursement Scenario
8.5.7.3.5. Saudi Arabia Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.7.4. UAE
8.5.7.4.1. Key Country Dynamics
8.5.7.4.2. Competitive Scenario
8.5.7.4.3. Regulatory Framework
8.5.7.4.4. Reimbursement Scenario
8.5.7.4.5. UAE Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
8.5.7.5. Kuwait
8.5.7.5.1. Key Country Dynamics
8.5.7.5.2. Competitive Scenario
8.5.7.5.3. Regulatory Framework
8.5.7.5.4. Reimbursement Scenario
8.5.7.5.5. Kuwait Parenteral Nutrition Market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Key Company Market Position Analysis
9.3. Key Company Market Share Analysis
9.4. Recent Development and Impact Analysis, by key Market Participants
9.5. Company Profiles
9.5.1. Braun Melsungen AG
9.5.1.1. Company Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic initiatives
9.5.2. Fresenius kabi AG
9.5.2.1. Company Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic initiatives
9.5.3. Allergan
9.5.3.1. Company Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic initiatives
9.5.4. Grifols S.A.
9.5.4.1. Company Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic initiatives
9.5.5. Pfizer Inc.
9.5.5.1. Company Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic initiatives
9.5.6. Otsuka Pharmaceutical Factory, Inc
9.5.6.1. Company Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic initiatives
9.5.7. Baxter
9.5.7.1. Company Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic initiatives
9.5.8. Aculife
9.5.8.1. Company Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic initiatives
9.5.9. Sichuan Kelun Pharmaceutical Co., Ltd
9.5.9.1. Company Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic initiatives
9.5.10. Vifor Pharma
9.5.10.1. Company Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 4 North America Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 5 North America Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 6 North America Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 7 U.S. Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 8 U.S. Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 9 U.S. Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 10 U.S. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 11 Canada Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 12 Canada Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 13 Canada Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 14 Canada Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 15 Europe Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 16 Europe Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 17 Europe Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 18 Europe Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 19 UK Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 20 UK Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 21 UK Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 22 UK Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 23 Germany Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 24 Germany Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 25 Germany Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 26 Germany Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 27 France Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 28 France Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 29 France Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 30 France Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 31 Italy Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 32 Italy Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 33 Italy Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 34 Italy Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 35 Spain Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 36 Spain Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 37 Spain Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 38 Spain Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 39 Sweden Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 40 Sweden Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 41 Sweden Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 42 Sweden Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 43 Denmark Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 44 Denmark Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 45 Denmark Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 46 Denmark Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 47 Norway Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 48 Norway Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 49 Norway Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 50 Norway Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 52 Asia Pacific Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 53 Asia Pacific Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 54 Asia Pacific Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 55 Japan Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 56 Japan Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 57 Japan Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 58 Japan Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 59 China Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 60 China Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 61 China Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 62 China Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 63 India Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 64 India Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 65 India Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 66 India Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 67 Australia Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 68 Australia Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 69 Australia Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 70 Australia Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 71 South Korea Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 72 South Korea Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 73 South Korea Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 74 South Korea Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 75 Thailand Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 76 Thailand Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 77 Thailand Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 78 Thailand Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 79 Latin America Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 80 Latin America Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 81 Latin America Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 82 Latin America. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 83 Brazil Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 84 Brazil Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 85 Brazil Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 86 Brazil Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 87 Mexico Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 88 Mexico Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 89 Mexico Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 90 Mexico. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 91 Argentina Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 92 Argentina Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 93 Argentina Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 94 Argentina Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 95 MEA Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 96 MEA Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 97 MEA Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 98 MEA Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 99 South Africa Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 100 South Africa Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 101 South Africa Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 102 South Africa Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 103 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 104 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 105 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 107 UAE Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 108 UAE Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 109 UAE Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 110 UAE Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
Table 111 Kuwait Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
Table 112 Kuwait Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
Table 113 Kuwait Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
Table 114 Kuwait Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)

★調査レポート[世界の非経口栄養剤市場2023-2030：ステージ種類別（成人、小児）、栄養素種類別、疾患別、販売チャネル別、地域別] (コード：GRV23AUG061)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の非経口栄養剤市場2023-2030：ステージ種類別（成人、小児）、栄養素種類別、疾患別、販売チャネル別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の低分子イノベーターCDMO市場2024-2030：製品別（低分子原薬、低分子医薬品）、ステージ種類別、顧客種類別、治療領域別、地域別
  • 世界の低分子イノベーターCDMO（医薬品受託製造）市場2023-2030：製品別（低分子原薬、低分子医薬品製品）、ステージ種類別、顧客種類別、治療領域別、地域別
  • 世界のインフルエンザワクチン市場2024-2030：ワクチン種類別（不活化、弱毒化）、疾患別、年齢層別、投与経路別、販売チャネル別、地域別
  • 世界のDTC遺伝子検査市場2024-2030：検査タイプ別（ニュートリゲノミクス、キャリア）、技術別（全ゲノムシーケンス）、販売チャネル別、地域別
  • 世界の髄膜炎菌ワクチン市場2023-2030：ブランド別（Menactra、Menveo）、種類別、血清型別、年齢層別、販売チャネル別、地域別
  • 世界の抗真菌薬市場2024-2030：薬剤クラス別（アゾール系、ポリエン系）、効能・効果別（皮膚糸状菌症、アスペルギルス症）、剤形別、販売チャネル別、地域別
  • 世界のスポーツ栄養市場2024-2030：製品種類別（スポーツサプリメント、スポーツドリンク）、剤型別（液体、錠剤）、消費者グループ別、販売チャネル別、地域別
  • 世界の経腸栄養剤市場2023-2030：製品別、フロー種類別、年齢層別、疾患別、エンドユーザー別、販売チャネル別、地域別
  • 世界の経口臨床栄養市場2023-2030：ステージ別（成人、小児科）、疾患別（嚥下障害、アルツハイマー病）、販売チャネル別、地域別
  • 世界の経腸栄養製剤市場2024-2030：製品別（標準配合剤、疾患特異的配合剤）、フロー種類別、ステージ別、疾患別、エンドユーザー別、販売チャネル別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆